全文获取类型
收费全文 | 18443篇 |
免费 | 1173篇 |
国内免费 | 133篇 |
专业分类
耳鼻咽喉 | 157篇 |
儿科学 | 414篇 |
妇产科学 | 351篇 |
基础医学 | 2133篇 |
口腔科学 | 730篇 |
临床医学 | 1761篇 |
内科学 | 3970篇 |
皮肤病学 | 392篇 |
神经病学 | 1152篇 |
特种医学 | 423篇 |
外国民族医学 | 5篇 |
外科学 | 2431篇 |
综合类 | 482篇 |
一般理论 | 14篇 |
预防医学 | 1538篇 |
眼科学 | 732篇 |
药学 | 1775篇 |
中国医学 | 209篇 |
肿瘤学 | 1080篇 |
出版年
2024年 | 20篇 |
2023年 | 218篇 |
2022年 | 551篇 |
2021年 | 1071篇 |
2020年 | 705篇 |
2019年 | 849篇 |
2018年 | 1008篇 |
2017年 | 713篇 |
2016年 | 773篇 |
2015年 | 783篇 |
2014年 | 1046篇 |
2013年 | 1206篇 |
2012年 | 1643篇 |
2011年 | 1691篇 |
2010年 | 998篇 |
2009年 | 762篇 |
2008年 | 1108篇 |
2007年 | 985篇 |
2006年 | 829篇 |
2005年 | 707篇 |
2004年 | 554篇 |
2003年 | 457篇 |
2002年 | 392篇 |
2001年 | 51篇 |
2000年 | 58篇 |
1999年 | 58篇 |
1998年 | 50篇 |
1997年 | 44篇 |
1996年 | 43篇 |
1995年 | 35篇 |
1994年 | 18篇 |
1993年 | 33篇 |
1992年 | 24篇 |
1991年 | 17篇 |
1990年 | 19篇 |
1989年 | 20篇 |
1988年 | 19篇 |
1987年 | 12篇 |
1986年 | 14篇 |
1985年 | 12篇 |
1984年 | 19篇 |
1983年 | 17篇 |
1982年 | 16篇 |
1981年 | 11篇 |
1980年 | 12篇 |
1979年 | 13篇 |
1978年 | 10篇 |
1976年 | 10篇 |
1974年 | 8篇 |
1973年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
121.
122.
Mohammad Abuzeineh Yousuf Kyeso Mary Carmelle Philogene Nada Alachkar Sami Alasfar 《Transplantation proceedings》2021,53(5):1501-1508
BackgroundIt remains challenging to manage antibody-mediated rejection (ABMR) associated with angiotensin II type 1 receptor antibodies (AT1R-Abs) in kidney transplant recipients and the outcomes are not well defined. We describe the presentation, clinical course, and outcomes of this condition.MethodsThis retrospective study included kidney transplant recipients with AT1R-Ab levels ≥10 units/mL and biopsy-proven ABMR in the absence of significant HLA-donor-specific antibodies at the time of rejection.ResultsWe identified 13 recipients. Median creatinine (Cr) at rejection was significantly higher (2.05 mg/dL) compared with baseline (1.2 mg/dL), P = .006. After ABMR management, the difference in median Cr was not significant (1.5 mg/dL), P = .152. Median AT1R-Ab level was higher in the pretransplant sample (34.5 units/mL) compared with the level at rejection (19 units/mL) and after rejection treatment (13 units/mL); however, these differences were not significant, P = .129. Eight of the 13 recipients received antibody reduction therapy with plasmapheresis and intravenous immunoglobulin, and 5 of the 13 recipients had other therapies. After rejection management, 6 of the 13 recipients had improvement in Cr to baseline and 7 of the 13 recipients had > 50% reduction in proteinuria.ConclusionsAT1R-Ab–associated ABMR management and outcomes depend on the clinical presentation and may include antibody-reducing therapies among other therapies. Further prospective cohorts will improve recognizing and managing this condition. 相似文献
123.
Elham Torkamaniha Mohammad Amir Amirkhani Mostafa Dahmardehei Paolo Rebulla Andrea Piccin Shamim Hortamani Maryam Heidari‐Kharaji Parvin Mansouri Amir Ali Hamidieh Mohammad Ali Nilforoushzadeh 《Wound repair and regeneration》2021,29(1):134-143
Epidermolysis bullosa (EB) is a rare genetic disorder characterized by the formation of blisters and wounds in skin and mucous membranes; it is classified into four types and has various methods of treatment. Management of previous wounds and prevention of formation of new lesions are the most important strategies in the course of therapy to improve patient's quality of life; lack of wound management can lead to further complications such as infection. The current study investigated the therapeutic effects of allogeneic platelet gel (prepared from umbilical cord blood) in a group of children diagnosed with dystrophic epidermolysis bullosa (DEB) eligible for surgical correction of pseudosyndactyly in the hand. The post‐surgical clinical outcome in this group was compared with the clinical outcomes of DEB patients receiving the standard treatment (paraffin gauze wound dressing and topical antibiotics) after corrective surgery. The current study results showed an increase in the rate of recovery and promotion of tissue granulation, complete wound healing, and a decrease in pain level and treatment period. The application of cord blood platelet gel topical dressing was not a conventional method of treatment in patients with DEB wounds and blisters. However, the current study results demonstrated that this gel dressing could effectively accelerate epithelialization and healing of the wounds and decrease patients' pain and post‐surgical recovery period, which altogether leads to improvements in patients' overall quality of life. 相似文献
124.
Vignesh T. Packiam Craig V. Labbate Stephen A. Boorjian Robert Tarrell John C. Cheville Svetlana Avulova Vidit Sharma Matvey Tsivian Brittany Adamic Mohammad Mahmoud Ryan P. Werntz Norm D. Smith R. Jeffrey Karnes Matthew K. Tollefson Gary D. Steinberg Igor Frank 《Urologic oncology》2021,39(7):436.e1-436.e8
IntroductionWhile numerous current clinical trials are testing novel salvage therapies (ST) for patients with recurrent nonmuscle invasive bladder cancer (NMIBC) after bacillus Calmette-Guérin (BCG), the natural history of this disease state has been poorly defined to date. Herein, we evaluated oncologic outcomes in patients previously treated with BCG and ST who subsequently underwent radical cystectomy (RC).MethodsWe identified 378 patients with high-grade NMIBC who received at least one complete induction course of BCG (n = 378) with (n = 62) or without (n = 316) additional ST and who then underwent RC between 2000 and 2018. Oncologic outcomes were compared using the Kaplan-Meier method and Cox proportional hazards models. Sensitivity analyses were conducted stratifying by presenting tumor stage, matched 1:3 for receipt vs. no receipt of ST.ResultsPatients receiving ST were more likely to initially present with CIS (26% vs. 17%) and less likely with T1 disease (34% vs. 50%, P = 0.06) compared to patients not treated with ST. Receipt of ST was not associated with increased risk of adverse pathology (≥pT2 or pN+) at RC (31% vs. 41%, P = 0.14). Likewise, 5-year cancer-specific survival did not significantly differ between groups on univariable Kaplan-Meier analysis (73% for ST and 74% for no ST, P = 0.7). Moreover, on multivariable analysis, receipt of ST was not significantly associated the risk of death from bladder cancer (HR 1.12; 95% CI 0.60–2.09, P = 0.7). Results were unchanged on sensitivity analysis.ConclusionsThese data suggest that, in carefully selected patients, ST following BCG for high grade NMIBC does not compromise oncologic outcomes for patients who ultimately undergo RC. 相似文献
125.
Raji-amirhasani Alireza Khaksari Mohammad Darvishzadeh Mahani Fatemeh Hajializadeh Zahra 《Clinical and experimental nephrology》2021,25(8):807-821
Clinical and Experimental Nephrology - Acute kidney injury (AKI) is a complex disorder and a clinical condition characterized by acute reduction in renal function. If AKI is not treated, it can... 相似文献
126.
Saeed Shoar Fatemeh Sadat Hosseini Azouba Gulraiz Waleed Ikram Moiz Javed Mohammad Naderan Nasrin Shoar Venkat R. Modukuru 《Surgery for obesity and related diseases》2021,17(3):630-643
Even in the hands of highly experienced bariatric surgeons, perioperative complications are inevitable. Of these, leaks and fistulas are amongst the scariest complications. Intrathoracic gastric fistulas (ITGF) can be associated with serious morbidity, mostly when cases are misdiagnosed or detected with delay. This is a systematic review of the literature to investigate the clinical and surgical outcomes of morbidly obese adult patients with a confirmed diagnosis of ITGF following bariatric surgery. A pooled analysis of 25 articles, encompassing 76 patients with post-bariatric ITGF, showed that the clinical outcome depends on the initial presentation, timing of the diagnosis in relation to symptom onset, and prompt and effective treatment. Any septic or unstable patient must undergo urgent surgical intervention, while stable patients might tolerate a step-up approach and watchful waiting for nonsurgical treatment. Among those who undergo surgery, treatment failure and the mortality rate are substantially high. Contingent upon a prompt management strategy, patients with postbariatric ITGF can generally have a favorable outcome in the long term. 相似文献
127.
Mohammad Kermansaravi Shahab Shahabi Shahmiri Amir Hossein Davarpanah Jazi Rohollah Valizadeh Rudolf A. Weiner Sonja Chiappetta 《Surgery for obesity and related diseases》2021,17(8):1489-1496
This review evaluates the indications and outcomes of one-anastomosis/mini gastric bypass (OAGB/MGB) reversal to normal anatomy. A systematic literature search and meta-analysis was performed in PubMed, Web of Science, and Scopus for articles published by October 1, 2020, including the keywords “one anastomosis gastric bypass,” “OAGB,” “mini gastric bypass,” “MGB,” “reversal,” “reverse,” “malnutrition,” and “reversal bariatric surgery”. After examining 182 papers involving 11,578 patients, 14 studies were included. A reversal was performed in 119 patients on average 23.6 months after the primary OAGB/MGB surgery. The mean body mass index (BMI) was 22.92 ± 3.47 kg/m2 and the mean albumin level was 25.17 ± 4.21 g/L at reversal. The mean length of the common channel (CC) was 383.57 ± 159.35 cm, with a mean biliopancreatic limb (BPL) length of 214.21 ± 48.45 cm. Pooled estimation of the meta-analysis of prevalence studies reported a prevalence of 1% for reversal. The major signs and symptoms of protein-energy malnutrition were the leading causes of the reversal of OAGB/MGB. Bleeding, leakage, and death due to severe liver failure were the most reported complications after reversal, with an overall incidence of 10.9%. In conclusion, OAGB/MGB reversal has a prevalence of 1% and has a complication rate of 10.9%. Protein-energy malnutrition with hypoalbuminemia was the most common etiology. The mean lengths of BPL and CC were reported as 215 cm and 380 cm, respectively, in the cases. Therefore, special attention should be paid to malnutrition in all OAGB/MGB patients during follow-up to prevent severe malnutrition and subsequent increase in reversal procedures. 相似文献
128.
Jalaei Nobari Hossein Rashedi Jalil Mahdavi Poor Behroz Asgharzadeh Mohammad 《Archives of sexual behavior》2022,51(7):3219-3220
Archives of Sexual Behavior - 相似文献
129.
Hamed Nikoupour MD Peyman Arasteh MD MPH Alireza Shamsaeefar MD Fardin Ghanbari MD Arash Boorboor MD Ali Mosa Jafar Almayali MD Mojtaba Shafiekhani PharmD Ph.D Pirouz Samidoust MD Reza Shahriarirad MD Alireza Shojazadeh MD Keivan Ranjbar MD Mohammad Hasan Darabi MD Sina Tangestanipour MD Seyed Morteza Hosseini MD Leila Zahiri MD Saman Nikeghbalian MD 《JPEN. Journal of parenteral and enteral nutrition》2022,46(4):946-957
130.
Aileen Azari-Yaam Mohammad Reza Abdolsalehi Mohammad Vasei Moeinadin Safavi Mehrzad Mehdizadeh 《Head and neck pathology》2021,15(1):352
Rosai–Dorfman disease (RDD) is a rare and self-limiting disease process that presents most commonly in young patients as massive, painless, cervical lymphadenopathy. Extranodal involvement may also occur. Histopathologic evaluation is the main diagnostic modality. We report an unusual presentation of RDD with cervical lymphadenopathy and an incidentally discovered sinonasal mass, clinically worrisome for malignancy. We emphasize that a high index of clinical suspicion is critical for accurate diagnosis of RDD. Clinicians and pathologists should consider RDD in a differential diagnosis of cervical lymphadenopathy, especially in young patients. 相似文献